BioWorld

July 31, 2003

View Archived Issues

ILEX Raises $93.5M In Secondary Public Offering Of Common Stock

ILEX Oncology Inc. gained gross proceeds of $93.5 million through the sale of 5.5 million common shares priced at $17 apiece. (BioWorld Today) Read More

If Passed, BIOFIX Would Fix Broken Tax Code For Biotechs

Read More

The Six-Country WHO Network Hands Down Its Final Verdict: Coronavirus Is Behind SARS

Read More

BioAxone Making Progress In Spinal Cord Injuries, Cancer

Read More

Other News To Note

Read More